Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells
about
Transforming growth factor-beta1, transforming growth factor-beta2, and transforming growth factor-beta3 enhance ovarian cancer metastatic potential by inducing a Smad3-dependent epithelial-to-mesenchymal transitionAnimal models of ovarian cancerEstrogen, progesterone and epithelial ovarian cancerWWOX protein expression varies among ovarian carcinoma histotypes and correlates with less favorable outcomeHormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment ConsiderationsEstrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapyIdentification of ATF-3, caveolin-1, DLC-1, and NM23-H2 as putative antitumorigenic, progesterone-regulated genes for ovarian cancer cells by gene profilingRelationship between epidemiologic risk factors and hormone receptor expression in ovarian cancer: results from the Nurses' Health Study.Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha.A bifunctional platinum(II) antitumor agent that forms DNA adducts with affinity for the estrogen receptorHormonal regulation and distinct functions of semaphorin-3B and semaphorin-3F in ovarian cancer.DNA copy numbers profiles in affinity-purified ovarian clear cell carcinomaHE4 expression is associated with hormonal elements and mediated by importin-dependent nuclear translocationPrognostic value of progesterone receptor expression in ovarian cancer: a meta-analysisInduction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cellsIncreased androgen receptor expression in serous carcinoma of the ovary is associated with an improved survival.Estrogen signaling crosstalk: Implications for endocrine resistance in ovarian cancer.Expression and function of androgen receptor coactivator p44/Mep50/WDR77 in ovarian cancerChk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers.Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.Expression of mitochondrial regulators PGC1α and TFAM as putative markers of subtype and chemoresistance in epithelial ovarian carcinomaEstrogen and androgen receptor expression in surface epithelium and inclusion cyst in the ovary of premenopausal and postmenopausal womenAndrogen receptor cytosine, adenine, guanine repeats, and haplotypes in relation to ovarian cancer riskApplication of phi29 motor pRNA for targeted therapeutic delivery of siRNA silencing metallothionein-IIA and survivin in ovarian cancersIdentification of ovarian cancer associated genes using an integrated approach in a Boolean framework.Exploiting MEK inhibitor-mediated activation of ERα for therapeutic intervention in ER-positive ovarian carcinoma.Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinomaCharacterization of ascites-derived ovarian tumor cells from spontaneously occurring ovarian tumors of the chicken: evidence for E-cadherin upregulation.Risk factors for ovarian cancer: an overview with emphasis on hormonal factors.Preclinical evaluation on the tumor suppression efficiency and combination drug effects of fermented wheat germ extract in human ovarian carcinoma cells.Local estrogen metabolism in epithelial ovarian cancer suggests novel targets for therapy.Oral contraceptive use and reproductive factors and risk of ovarian cancer in the European Prospective Investigation into Cancer and NutritionThe effects of 17β-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis.Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.Early alterations in ovarian surface epithelial cells and induction of ovarian epithelial tumors triggered by loss of FSH receptor.Loss of ERbeta expression as a common step in estrogen-dependent tumor progressionEstrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesisBisphenol A and hormone-associated cancers: current progress and perspectivesThe progesterone receptor PROGINS polymorphism is not related to oxidative stress factors in women with polycystic ovary syndromeSex Steroid Hormone Receptor Expression Affects Ovarian Cancer Survival.
P2860
Q24316645-89DB1E9F-6127-4361-A784-A3B7C2244325Q24791470-5DA7D29F-7394-4CCF-B801-C6C9E09AB3BEQ24805637-6EDD3837-2D70-499A-920E-288814FE2596Q24815527-99F0DBE6-56B7-486A-AC2B-282F26371E37Q26751021-9E7C2C61-1678-408C-AF8E-9B37D5B5D728Q28109453-9ADE03E1-D1D3-480E-933F-5B67809F9A3FQ28304574-109EE901-F343-476B-BE3D-2E1B064CFA89Q33623349-E329CB4C-4022-4F8B-910A-BB674D26A487Q33642747-8AFE4D71-4C0E-464F-A02C-AB52BC71D1C5Q33642960-DEE210FE-43AE-4248-84F9-4874C3E057FBQ33647661-0DBBC881-4607-42DC-95AA-2EF06FC2EA06Q33767047-1980D37F-83AE-4F37-8A2A-6EF007BC87F3Q33820206-536E00CF-0168-436C-B09B-E94C711AFF0FQ33829679-DD513F20-23B9-498E-98E1-7534022FD29BQ33963529-D89035AF-B1A4-490A-8C2F-94F7D82026D9Q33986711-D8671331-1196-4232-80F2-E905A35E9481Q34022694-F45B9E35-4791-4DD8-96FB-A53A9FD33FB5Q34056207-64898627-CB6E-4914-810C-B2DAE456466BQ34062570-54ADC094-7022-4C44-916D-A95D91DE82A5Q34200707-3C7A43A4-073B-49AC-B86D-769FF32E32C1Q34223682-BC5E270A-ED16-476F-A1D9-7331A19A1336Q34249388-30C833C8-6F82-43DE-974E-1862986E1D57Q34345107-06AE28B9-C0AB-4C6A-AEC7-3DF3C63681CFQ34556898-CC7B15E8-1319-4941-9F9F-203066F36DFAQ34577355-7C216F18-E3D3-4116-A7FE-47EF59D3C3F0Q34579904-BE03BD66-7CE7-40A8-8DA4-A3115AB830B8Q34595670-6689C61E-8216-4368-8B56-3313854995B0Q34608699-5EB08CA1-5476-40EE-9D57-DB18907FAE23Q34764768-F773BF89-B7DE-47D8-AB54-C037FA34AE36Q35178056-E1B7FCBE-D7D0-48D9-A610-624DF59B2812Q35600183-46C91A69-198B-4F53-B4CE-D83D72BC44F3Q35620640-C8FBFFFC-E5AF-4087-8ED1-160A0605835FQ35646553-9146BF99-05DF-458F-A19A-0A14CA7DD141Q35787316-D92FAAEA-2B22-4259-8619-E2F537F3FF9DQ35855100-3F6A977A-7428-4291-B879-59E257778ADFQ35888377-AEBA7F2D-9B05-4986-8FEF-6719F379AE60Q35929364-C5B63FB6-F38B-40A3-857B-EFF7D47B2A9CQ36152737-5F0D3DCB-7729-4FE5-B9C9-D21BEE443D0AQ36169983-21086619-CB5E-4268-ADE5-3E3E3D1A62AFQ36243394-861137D8-A23F-4231-AE63-BB1424A4F769
P2860
Expression of human estrogen receptor-alpha and -beta, progesterone receptor, and androgen receptor mRNA in normal and malignant ovarian epithelial cells
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Expression of human estrogen r ...... gnant ovarian epithelial cells
@ast
Expression of human estrogen r ...... gnant ovarian epithelial cells
@en
type
label
Expression of human estrogen r ...... gnant ovarian epithelial cells
@ast
Expression of human estrogen r ...... gnant ovarian epithelial cells
@en
prefLabel
Expression of human estrogen r ...... gnant ovarian epithelial cells
@ast
Expression of human estrogen r ...... gnant ovarian epithelial cells
@en
P2860
P356
P1476
Expression of human estrogen r ...... gnant ovarian epithelial cells
@en
P2860
P304
P356
10.1073/PNAS.96.10.5722
P407
P50
P577
1999-05-01T00:00:00Z